InspireMD (NSPR) announced the appointment of Raymond W. Cohen to its Board of Directors. Until May of 2025, Mr. Cohen served as Chairman of SoniVie, a clinical stage company focused on a device treatment for hypertension until it was acquired by Boston Scientific for $600 million.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NSPR:
